EMR Intercountry Workshop, December |1 | VP-IBD Surveillance Data, 2009 Photo: Dr. Mary Agócs

EMR Intercountry Workshop, December |2 |

3 |3 | VP-IBD and Rotavirus Global and Regional Laboratory Network Structure, 2010 WHO Regional Reference Laboratories WHO Global Reference Laboratories Global: IBD & Rota Rota IBD IBD & Rota IBD Rota IBD Rota IBD

EMR Intercountry Workshop, December |4 | Countries in WHO VP-IBD Surveillance Network, by WHO Region and GAVI Eligibility, / 47 reporting countries are GAVI-eligible= 72%

EMR Intercountry Workshop, December |5 | Tier 1 VP-IBD Countries: Meningitis Surveillance

EMR Intercountry Workshop, December |6 | Tier 1: Meningitis Surveillance Data, 2008 Compared with 2009 India, Philippines, and Viet Nam join the network in 2009

AMR AFR EMR SEAR WPR EUR

AMR AFR EMR SEAR WPR EUR

EMR Intercountry Workshop, December |9 | % Probable Bacterial Meningitis Cases with HI, by Years of Hib Vaccine Introduction & WHO Region, 2009 (regional medians with country-specific ranges)

Data collected from WHO Regions and partners and WHO/IVB Database as of September Invasive Bacterial Diseases Surveillance Tier 2 Slide date: 16 September 2010 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved 16 Countries VP-IBD Surveillance: Tier 2 Meningitis-Sepsis-Pneumonia Surveillance

EMR Intercountry Workshop, December | IBD Surveillance, Tier 2 Meningitis-Sepsis-Pneumonia Numbers of reporting countries & children enrolled with pneumonia with % change from 2008 to 2009, by WHO region SEAR: increased reporting from Bangladesh & Nepal

EMR Intercountry Workshop, December | Tier 2: Meningitis-Pneumonia-Sepsis Detected Organisms, 2009

% serotypes in PCV-7, 10, and 13 AFR: 48%, 80%, and 91%, SEAR: and 44%, 69%, and 75%, Spn. Serotype Data, Tier 1: Meningitis

EMR Intercountry Workshop, December | Rotavirus Surveillance, 2009 Photo: Dr. Duncan Steele

EMR Intercountry Workshop, December | Rotavirus Surveillance Countries Participating in the WHO Network and Reporting Data for 2009 Data collected from WHO Regions. Slide date: 2 August 2010 Yes (55 Member States or 28% of Member States)

EMR Intercountry Workshop, December | IBD and Rotavirus Global and Regional Laboratory Network Structure, 2010 WHO Regional Reference Laboratories WHO Global Reference Laboratories Global: IBD & Rota Rota IBD IBD & Rota IBD Rota IBD Rota IBD

EMR Intercountry Workshop, December | Countries in the WHO Rotavirus Surveillance Network, by WHO Region & GAVI Eligibility, / 55 are GAVI-eligible= 62%

EMR Intercountry Workshop, December | Rotavirus Surveillance 2008 Compared with 2009 SEAR: Indonesia and Sri Lanka joined in 2009 NOTE: No data from the AMR countries of St. Vincent & Grenadines and Surinam.

EMR Intercountry Workshop, December | AMR AFR EMR EUR SEAR WPR

EMR Intercountry Workshop, December | % Positive for Rotavirus, WHO Regional Medians and Ranges, 2009 Country-specific Ranges (%) Median (%) No. (%) Reporting Countries WHO region 15 – (22)AFR 0 – (25)AMR 14 – (24)EMR 12 – (11)EUR 26 – (7)SEAR 24 – (11)WPR 0 – (100)TOTAL Countries using rotavirus vaccine: Bolivia, Colombia, Ecuador, El Salvador, Honduras, Nicaragua, Panama, Venezuela

EMR Intercountry Workshop, December | Genotypes, 2009 n=2,782 Countries using rotavirus vaccine: Nicaragua, El Salvador